东诚药业(002675.SZ)：注射用氢化可的松琥珀酸钠通过仿制药一致性评价

智通财经2025-05-06

智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司全资子公司烟台东诚北方制药有限公司(“东诚北方”)收到国家药品监督管理局核准签发的关于注射用氢化可的松琥珀酸钠的《药品补充申请批准通知书》，东诚北方生产的注射用氢化可的松琥珀酸钠通过仿制药质量和疗效一致性评价。公告显示，本品为肾上腺皮质激素类药。氢化可的松琥珀酸钠是氢化可的松的盐类化合物，具有抗炎、抗过敏和抑制免疫等多种药理作用。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533687311?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-06 19:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533687311","market":"sh","top_or_hot":-1,"title":"东诚药业(002675.SZ)：注射用氢化可的松琥珀酸钠通过仿制药一致性评价","media":"智通财经","content":"<div>\n<p>智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司全资子公司烟台东诚北方制药有限公司(“东诚北方”)收到国家药品监督管理局核准签发的关于注射用氢化可的松琥珀酸钠的《药品补充申请批准通知书》，东诚北方生产的注射用氢化可的松琥珀酸钠通过仿制药质量和疗效一致性评价。公告显示，本品为肾上腺皮质激素类药。氢化可的松琥珀酸钠是氢化可的松的盐类化合物，具有抗炎、抗过敏和抑制免疫等多种药理作用。...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289786.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>东诚药业(002675.SZ)：注射用氢化可的松琥珀酸钠通过仿制药一致性评价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n东诚药业(002675.SZ)：注射用氢化可的松琥珀酸钠通过仿制药一致性评价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-06 19:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1289786.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司全资子公司烟台东诚北方制药有限公司(“东诚北方”)收到国家药品监督管理局核准签发的关于注射用氢化可的松琥珀酸钠的《药品补充申请批准通知书》，东诚北方生产的注射用氢化可的松琥珀酸钠通过仿制药质量和疗效一致性评价。公告显示，本品为肾上腺皮质激素类药。氢化可的松琥珀酸钠是氢化可的松的盐类化合物，具有抗炎、抗过敏和抑制免疫等多种药理作用。...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289786.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1289786.html","article_id":"2533687311","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533687311","pubTimestamp":1746532327,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，东诚药业 发布公告，近日，公司全资子公司烟台东诚北方制药有限公司收到国家药品监督管理局核准签发的关于注射用氢化可的松琥珀酸钠的《药品补充申请批准通知书》，东诚北方生产的注射用氢化可的松琥珀酸钠通过仿制药质量和疗效一致性评价。氢化可的松琥珀酸钠是氢化可的松的盐类化合物，具有抗炎、抗过敏和抑制免疫等多种药理作用。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0239":"医药制造","002675":"东诚药业"},"translate_title":"Dongcheng Pharmaceutical (002675. SZ): Hydrocortisone sodium succinate for injection passed the consistency evaluation of generic drugs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002675":1},"content_text":"智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司全资子公司烟台东诚北方制药有限公司(“东诚北方”)收到国家药品监督管理局核准签发的关于注射用氢化可的松琥珀酸钠的《药品补充申请批准通知书》，东诚北方生产的注射用氢化可的松琥珀酸钠通过仿制药质量和疗效一致性评价。公告显示，本品为肾上腺皮质激素类药。氢化可的松琥珀酸钠是氢化可的松的盐类化合物，具有抗炎、抗过敏和抑制免疫等多种药理作用。用于抢救危重病人如中毒性感染、过敏性休克、严重的肾上腺皮质功能减退症、结缔组织病、严重的支气管哮喘等过敏性疾病，并可用于预防和治疗移植物急性排斥反应。注射用氢化可的松琥珀酸钠属于《国家基本药物目录》与《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》甲类品种，根据有关统计数据显示，2024年中国公立医疗机构注射用氢化可的松琥珀酸钠销售额约为人民币1.88亿元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533687311","isCrawlerRequest":true}